Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2019-04-15
2019-12-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, the present study will compare the muscle anabolic response between mycoprotein (MYC) as a whole food and the protein isolated from mycoprotein (PIM).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mycoprotein and Pea Protein Blend and Muscle Protein Synthetic Response
NCT04894747
Does the Ingestion of Mycoprotein Elicit an Optimal Anabolic Response in Resting and Exercised Skeletal Muscle?
NCT02984345
Mycoprotein, Resistance Training, and Hypertrophy
NCT03572127
The Muscle Protein Synthetic Response of Algal and Fungal Protein
NCT05016557
Protein Extrusion and Postprandial Amino Acid Handling
NCT05584358
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mycoprotein
Mycoprotein in its full food matrix
Mycoprotein ingestion
The ingestion of mycoprotein
Protein Isolated from Mycoprotein
Protein from mycoprotein isolated from the food matrix
Mycoprotein ingestion
The ingestion of mycoprotein
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mycoprotein ingestion
The ingestion of mycoprotein
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Resistance trained
Exclusion Criteria
* Cardio/pulmonary diseases.
* Chronic use of over the counter pharmaceuticals
* A personal or family history of epilepsy, seizures or schizophrenia.
* Allergic to mycoprotein/Quorn/edible fungi/environmental mould products.
18 Years
40 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Quorn
INDUSTRY
University of Exeter
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Exeter
Exeter, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
190206/B/07UOE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.